WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that the Company will host a conference call at 4:30 p.m. ET on Thursday, October 27, 2011, to discuss ImmunoGen's financial results for the three-month period ended September 30, 2011 – the first quarter of the Company’s 2012 fiscal year. Management also will provide an update on the Company.
